Fingerpaint Group, a 2022 MM+M Agency 100 honoree, announced Tuesday morning that it has snapped up PharmaHEALTHLabs, a healthcare communications agency that specializes in the oncology and biologics space.

Terms of the transaction were not disclosed but PharmaHealthLabs will be rebranded as Fingerpaint Medical Communications and folded under Fingerpaint Group’s Specialty Services offerings.

In a statement, Fingerpaint Group’s global president Bill McEllen noted that this is the company’s third medical communications acquisition in two years as well as the second featuring a “hyperfocused” specialty. 

“As therapies in the oncology and biologics space become more complex, Fingerpaint Medical Communications’ ability to distill the necessary elements of effective communication and optimize strategic execution has never been more critical,” McEllen said.  

For its part, PharmaHealthLabs was assisted in the deal by Excel Partners, which acted as its exclusive financial advisor.

“Our deep scientific knowledge ensures each project is not only compelling and engaging, but also simple to understand and communicate,” said Jennifer Harmon, co-founder and managing director of PharmaHealthLabs, in a statement. “Joining Fingerpaint Group will provide our employees with opportunities for growth and give our customers access to the extensive solutions that Fingerpaint Group offers at every phase of the commercialization process.”

Indeed the past few months have been a busy time at Fingerpaint Group filled with deals and announcements.

In September, the company acquired Boston-based Parsons Medical Communications, a full-service agency targeting the eye care industry. The organization has completed six acquisitions since it took on private equity partner Knox Lane in December 2020.

Fingerpaint Group also added network veteran Leo Tarkovsky as chief commercial officer that same month. Reporting to McEllen, Tarkovsky told MM+M he looks forward to using his considerable industry experience to boost the company’s growth trajectory.

“For me, this was an opportunity to join this dynamic team and bring my skills and expertise to the table so we can scale it to the next level,” he said. “I just couldn’t pass up a chance to build and scale something extraordinary.”

Weeks later, it rolled out Elevalt, a tool designed to streamline and optimize omnichannel marketing processes. 

To end the year, the agency rebranded its market access arm, 1798, as Fingerpaint Market Access.